• Research and education cooperations strengthened

    Barcelona/Amsterdam – 1 June 2012 – IESE Business School in cooperation with Intrabond Capital Corporation (Dr. Rodria Laline) and The Decision Institute (Prof. Dr. Fred van Eenennaam) have joined forces to bring the much acclaimed ‘Maximize Your Board’s Potential’ seminar on corporate governance to European soil.

    IESE Business School published a press release on the cooperation with The Decision Institute , partner of The Decision Group. A European edition of the successful Maximize Your Board’s Potential is designed and will be held in 2013.

    • Read the complete press release of IESE
    • Visit The Decision Institute website for more information on our Maximize Your Board’s Potential seminar
    • Register now for the 3rd edition by filling in the application form.

    Academic Collaborations

    On the areas of Research, Education and Academic Grounding of methodologies and projects, The Decision Group collaborates with various world class universities and business schools. The last months, these collaborations and our Academic Connections are further strengtened and expanded. On June 27, our International Academic Advisory Council on Life Sciences and Clusters will meet again to support development of the Dutch Life Sciences & Health Outlook 2013 with an exclusive visit to the Netherlands.

    • See also:

    The Decision Group:
    our expertise on Corporate Governance
    Dutch Life Sciences Outlook 2012

    The Decision Institute executive (board) programs:
    Maximize Your Boards Potential 2nd edition
    Maximize Your Boards Potential 1st edition
    NCD Commissarissencyclus
    New Board Program
    The Brain in the Boardroom
    New CFO Program

    Continue reading
  • The Decision Group started development of Dutch Life Sciences & Health Outlook 2013.

    Following the positive response on the Dutch Life Sciences Outook 2012, The Decision Group just started the development of the Outlook 2013. The database is updated again, startup companies are added and new developments are analyzed. The Academic Council will meet as well for thorough academic grounding of our theoretic models and validation of our methodologies.  We expect that the new outlook will be launched in Januari, 2013.

    Healthcare Section in Outlook 2013

    The aim of the new outlook 2013 is to address the convergence of innovation in healthcare. At this stage, The Decision Group is exploring options and opportunities for including a healthcare section in the outlook. A partner has already been selected.

    For questions, suggestion or more information about the Outlook 2013, please contact Niels van Gorp, ir.
    The Dutch Life Sciences Outlook of 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.

    See also

    The Decision Group Strategy Consulting:
    Consulting on Competitiveness & Clusters
    Consulting on Healthcare
    Consulting on Life Sciences

    The Decision Institute: Clusters and Competitiveness:
    The Netherlands Institute of Competitiveness
    Microeconomics of Competitiveness
    The Dutch Flower Cluster Case

    Continue reading
  • Dutch Economic Strategy Discussed with Harvard students

    Prof. Dr. Fred van Eenennaam, partner of The Decision Group and Dirk Hogervorst, of FloraHolland, acted as case protagonists in Prof. Michael Porters’s teaching of the Dutch Flower Cluster case. The topics discussed were on strategies in clusters and competitiveness in relation to the Dutch Economy. The Dutch Flower Cluster Case, the succes story of the flower industry in The Netherlands, is a Harvard Business School case written by Prof. Porter, Dr. Ramirez-Vallejo and Prof. Dr. Fred van Eenennaam with the help of Dirk Hogervorst of FloraHolland. The flower industry is important for the Dutch economy and part of the topsector horticulture & propagation materials. With topsectors, the Dutch government has set a focus on core clusters for innovation policy.  

    The Decision Group and Clusters and Competitiveness

    The Decision Group has extensive expertise in competitiveness, clusters and associations. Our work in clusters has academic grounding through Prof. Dr. Fred van Eenennaam’s connects to Harvard’s  Microeconomics of Competitiveness course and international network. The Decision Group helps monitoring clusters success, develops strategic plans and scenario’s, and is active in association management. For 4 years now, The Decision Group develops a yearly Outlook for the Dutch Life Science Health cluster, monitoring performance & progress with recommendations for future improvement. The Decision Group just started development of the Dutch Life Sciences & Health Outlook 2013. 

    See also

    The Decision Group Strategy Consulting on Competitiveness & Clusters:
    Consulting on Competitiveness & Clusters

    The Dutch Life Sciences Outlook:
    –  Outlook 2012

    The Decision Institute: Clusters and Competitiveness:
    The Netherlands Institute of Competitiveness
    Microeconomics of Competitiveness
    The Dutch Flower Cluster Case

    Continue reading
  • Dutch Life Sciences Outlook 2012 in the news

    After the successful launch of the Dutch Life Science Outlook 2012,  Dutch media published the report’s key messages in newspapers, and in newsitems on Dutch television. 

    Key messages

    Most attention was paid to the survey-based forecasts that start-up and smaller companies in the biotechnology will get under high pressure if they don’t get access to private and public investments. Contrary to the focus chosen by Dutch newspapers, the key conclusions from the Outlook 2012 according to The Decision Group are:

    • Growth and outperformance: The Dutch lsh cluster shows growth in size and products and ouperforms the Dutch economy on growth in number of companies and employment.
    • Positive Expectations: Entrepreneurs have positive expectations of the future despite disappearence of large companies.
    • Partnering: Facilitating (international) partnerships remains very important or future growth of the companies in the Dutch lsh cluster.

     Het Financieel Dagblad, the newspaper with an economic and financial focus, spent two articles on the Dutch Life Science Outlook 2012:
    Geldstroom ‘life sciences’ dreigt op te drogen – FD of Thursday 19 January 2012, page 14
    Subsidie schraagt groei life sciences – FD of Monday 23 January 2012

    Furthermore, a special news item about the changes in the Life Sciences Sector based on the Outlook, was broadcast by RTL Z, the financial news channel.

    Life Sciences and The Decision Group

    The Decision Group has extensive expertise on Life Sciences. Our client list includes many companies in big pharma as well as in medical devices and biotech. This expertise is underlined by the yearly published Dutch Life Sciences Outlook.

    More information about The Decision Group’s work on Life Sciences can be found on our special website.
    The Dutch Life Sciences Outlook 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.
    Official press release of Outlook 2012 by Life Science & Health: Stijging aantal bedrijven en werkgelegenheid biotech sector

    Continue reading
  • Dutch Life Sciences Outlook 2012 released

    On Wednesday January 18th, Prof. dr. F. van Eenennaam, partner of The Decision Group, presented the Dutch Life Sciences Outlook for a group of  60 key stakeholders in Life Sciences. The Outlook yearly monitors Dutch Life Sciences & Health Cluster success and measures  performance and progress of the sector. This yearly systematic Outlook is created in close collaboration between The Decision Group and Life Sciences Health.

    Clusters & Competitiveness

    Prior to presenting the Outlook, Prof dr. F. van Eenennaam gave a Masterclass on Cluster Development, where theory and practicalities of clusters were discussed, as well as implications for Dutch policy makers. The Decision Group has extensive expertise on Clusters & Competitiveness. See also our Clusters & Competitiveness website

    The Dutch Life Sciences Outlook 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.

    Continue reading
  • Decision Group methodology part of topsector Life Science & Health plan

    Plans for the Dutch topsectors LSH sector presented to Minister Verhagen

    The 9 topsectors the Dutch government has assigned presented their individual sectorplans to the minister of Economic Affairs on friday June 17th.  Life Sciences and Health is one of the 9 topsectors that presented their ambition and action agenda for the next 10-15 years. To measure progress on the action agenda, the methodology developed by The Decision Group together with Life Science & Health innovationprogramme is mentioned.

    Measuring methodology

    The methodology that was developed by The Decision Group to monitor the performance and progress in the Dutch Life Sciences & Health (LSH) sector has been acknowledged by the topsector. Our data on the core of innovative companies in the Dutch cluster was used to indicate the size and output of the cluster. And moreover, the way we measure the size, in-  and output of the Dutch LSH cluster  is seen as a proven methodology to monitor progress of the cluster’s ambition and agenda and provides a baseline for measuring progress in the next years.

    To request a copy of the Dutch Life Sciences Outlook 2011, click here.

    To read more on the Dutch Life Sciences Outlook, see here.

    Click the picture to enlarge.

    Continue reading